• Top
• Correction
• References
• Pre-publication history

Correction

Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

Paul D Carey¹ , Bavanisha Vythilingum¹ , Soraya Seedat¹ , Jacqueline E Muller¹ , Michael van Ameringen² and Dan J Stein¹

¹MRC Research Unit on Anxiety Disorders, University of Stellenbosch, Cape Town, South Africa

²Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada

author email corresponding author email

BMC Psychiatry 2005, 5:44doi:10.1186/1471-244X-5-44

The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-244X/5/44

Received:	25 November 2005
Accepted:	30 November 2005
Published:	30 November 2005

© 2005 Carey et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Correction

The comment in the introduction of our article [1] suggesting that "quetiapine is the only available antipsychotic with significant 5-HT1D effects," is misleading. The affinity of quetiapine for this receptor is low and probably insignificant when compared with some other second generation antipsychotics [2].

References

1. Carey PD, Vythilingum B, Seedat S, Muller JE, van AM, Stein DJ: Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762].

   BMC Psychiatry 2005, 5:5. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text

2. Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds.

   Life Sci 2000, 68:29-39. PubMed Abstract | Publisher Full Text

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1471-244X/5/44/prepub

Have something to say? Post a comment on this article!